Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
Authors:
Open Access
- 1 January 2014
- journal article
- review article
- Published by Wiley in Mediators of Inflammation
- Vol. 2014, 1-15
Abstract
Chemokines were initially identified as bioactive substances, which control the trafficking of inflammatory cells including granulocytes and monocytes/macrophages. Moreover, chemokines have profound impacts on other types of cells associated with inflammatory responses, such as endothelial cells and fibroblasts. These observations would implicate chemokines as master regulators in various inflammatory responses. Subsequent studies have further revealed that chemokines can regulate the movement of a wide variety of immune cells including lymphocytes, natural killer cells, and dendritic cells in both physiological and pathological conditions. These features endow chemokines with crucial roles in immune responses. Furthermore, increasing evidence points to the vital effects of several chemokines on the proliferative and invasive properties of cancer cells. It is widely acknowledged that cancer develops and progresses to invade and metastasize in continuous interaction with noncancerous cells present in cancer tissues, such as macrophages, lymphocytes, fibroblasts, and endothelial cells. The capacity of chemokines to regulate both cancerous and noncancerous cells highlights their crucial roles in cancer development and progression. Here, we will discuss the roles of chemokines in carcinogenesis and the possibility of chemokine targeting therapy for the treatment of cancer.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science, and Technology
This publication has 125 references indexed in Scilit:
- The Chemokine Superfamily RevisitedImmunity, 2012
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysisBritish Journal of Cancer, 2011
- CXCR3 in T cell functionExperimental Cell Research, 2011
- Chemokines as mediators of tumor angiogenesis and neovascularizationExperimental Cell Research, 2011
- Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine, 2010
- Tumor Self-Seeding by Circulating Cancer CellsCell, 2009
- Role of CXCR4/SDF-1α in the migratory phenotype of hepatoma cells that have undergone epithelial–mesenchymal transition in response to the transforming growth factor-βCellular Signalling, 2009
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival SignalsCancer Cell, 2009
- Cancer related inflammation: The macrophage connectionCancer Letters, 2008